Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats

European Journal of Pharmacology

Volumn 725, Issue 1, 2014, Pages 32-39

  Su, Yun Ai ^a,b   Huang, Run Hu ^a,b,c   Wang, Xiao Dong ^a,b   Li, Ji Tao ^a,b   Si, Tian Mei ^a,b  

^a BEIJING HOSPITAL   (China)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c Shanxi Dayi Hospital   (China)

Author keywords

Galantamine; MK 801; Schizophrenia; Working memory

Indexed keywords

DIZOCILPINE; GALANTAMINE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; LATENT PERIOD; LOCOMOTION; MALE; MEMORY DISORDER; NEWBORN; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; STARTLE REFLEX; WORKING MEMORY;

GALANTAMINE; MK-801; SCHIZOPHRENIA; WORKING MEMORY;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BODY WEIGHT; CHOLINESTERASE INHIBITORS; DIZOCILPINE MALEATE; FEMALE; GALANTAMINE; LOCOMOTION; MALE; MEMORY, SHORT-TERM; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SPATIAL BEHAVIOR;

EID: 84893422763     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.007     Document Type: Article

References (48)

1. A. Abi-Dargham, O. Mawlawi, I. Lombardo, R. Gil, D. Martinez, Y. Huang, D.R. Hwang, J. Keilp, L. Kochan, R. Van Heertum, J.M. Gorman, and M. Laruelle Prefrontal dopamine D1 receptors and working memory in schizophrenia J. Neurosci. 22 2002 3708 3719 (Pubitemid 37465776)
2. S. Akbarian, N.J. Sucher, D. Bradley, A. Tafazzoli, D. Trinh, W.P. Hetrick, S.G. Potkin, C.A. Sandman, W.E. Bunney Jr., and E.G. Jones Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics J. Neurosci. 16 1996 19 30 (Pubitemid 26010694)
3. K.S. Alexander, H.Q. Wu, R. Schwarcz, and J.P. Bruno Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine Psychopharmacology (Berl) 220 2012 627 637
4. K.S. Alexander, A. Pocivavsek, H.Q. Wu, M.L. Pershing, R. Schwarcz, and J.P. Bruno Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine Neuroscience 238 2013 19 28
5. J.D. Andersen, and B. Pouzet Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of d-serine Neuropsychopharmacology 29 2004 1080 1090 (Pubitemid 38670046)
6. F. Benetti, P.B. Mello, J.S. Bonini, S. Monteiro, M. Cammarota, and I. Izquierdo Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine Int. J. Dev. Neurosci. 27 2009 59 64
7. T.M. du Bois, and X.F. Huang Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia Brain Res. Rev. 53 2007 260 270
8. T.M. du Bois, C.W. Hsu, Y. Li, Y.Y. Tan, C. Deng, and X.F. Huang Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade Neurochem. Res. 33 2008 1224 1231
9. T.M. du Bois, C. Deng, M. Han, K.A. Newell, and X.F. Huang Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade Eur. Neuropsychopharmacol. 19 2009 256 265
10. T.M. du Bois, K.A. Newell, M. Han, C. Deng, and X.F. Huang Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 37 40
11. R.W. Buchanan, R.R. Conley, D. Dickinson, M.P. Ball, S. Feldman, J.M. Gold, and R.P. McMahon Galantamine for the treatment of cognitive impairments in people with schizophrenia Am. J. Psychiatry 165 2008 82 89 (Pubitemid 351704556)
12. A. Contestabile Roles of NMDA receptor activity and nitric oxide production in brain development Brain Res. Brain Res. Rev. 32 2000 476 509 (Pubitemid 30171317)
13. J.L. Eisele, S. Bertrand, J.L. Galzi, A. Devillers-Thiery, J.P. Changeux, and D. Bertrand Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities Nature 366 1993 479 483 (Pubitemid 24013884)
14. B. Fagerlund, T. Mackeprang, A. Gade, and B.Y. Glenthoj Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients CNS Spectr. 9 2004 364 374 (Pubitemid 38649725)
15. R. Freedman, S. Leonard, J.M. Gault, J. Hopkins, C.R. Cloninger, C.A. Kaufmann, M.T. Tsuang, S.V. Farone, D. Malaspina, D.M. Svrakic, A. Sanders, and P. Gejman Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) Am. J. Med. Genet. 105 2001 20 22
16. J.I. Friedman Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists Psychopharmacology (Berl) 174 2004 45 53 (Pubitemid 38925090)
17. J.A. Gorter, and J.P. de Bruin Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat Brain Res. 580 1992 12 17
18. A.J. Grottick, R. Wyler, and G.A. Higgins A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task Pharmacol. Biochem. Behav. 70 2001 505 513 (Pubitemid 34131645)
19. C. Guo, Y. Yang, Y. Su, and T. Si Postnatal BDNF expression profiles in prefrontal cortex and hippocampus of a rat schizophrenia model induced by MK-801 administration J. Biomed. Biotechnol. 2010 2010 783297
20. L.W. Harris, T. Sharp, J. Gartlon, D.N. Jones, and P.J. Harrison Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism Eur. J. Neurosci. 18 2003 1706 1710 (Pubitemid 37215123)
21. P.D. Harvey, and R.S. Keefe Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment Am. J. Psychiatry 158 2001 176 184 (Pubitemid 32116511)
22. C. Ikonomidou, F. Bosch, M. Miksa, P. Bittigau, J. Vockler, K. Dikranian, T.I. Tenkova, V. Stefovska, L. Turski, and J.W. Olney Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 283 1999 70 74 (Pubitemid 29044848)
23. K. Kawabe, and E. Miyamoto Effects of neonatal repeated MK-801 treatment on delayed nonmatching-to-position responses in rats Neuroreport 19 2008 969 973
24. K. Kawabe, T. Iwasaki, and Y. Ichitani Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning Brain Res. 1169 2007 77 86 (Pubitemid 47374093)
25. J.S. Kim, H.H. Kornhuber, W. Schmid-Burgk, and B. Holzmuller Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci. Lett. 20 1980 379 382 (Pubitemid 11160082)
26. D.S. Knopman, and J.C. Morris An update on primary drug therapies for Alzheimer disease Arch. Neurol. 54 1997 1406 1409 (Pubitemid 27469357)
27. E.D. Levin, C. Bettegowda, J. Blosser, and J. Gordon AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats Behav. Pharmacol. 10 1999 675 680 (Pubitemid 30026062)
28. A.L. Lim, D.A. Taylor, and D.T. Malone Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research Behav. Brain Res. 227 2012 276 286
29. L.E. Long, D.T. Malone, and D.A. Taylor Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice Neuropsychopharmacology 31 2006 795 803
30. â nicotinic receptors. Pharmacol. Exp. Ther. 322 2007 48 58 (Pubitemid 46956368)
31. R.L. McLamb, L.R. Williams, K.P. Nanry, W.A. Wilson, and H.A. Tilson MK-801 impedes the acquisition of a spatial memory task in rats Pharmacol. Biochem. Behav. 37 1990 41 45 (Pubitemid 20341683)
32. H.Y. Meltzer, and S.R. McGurk The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr. Bull. 25 1999 233 255 (Pubitemid 29272503)
33. B. Monti, and A. Contestabile Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum Eur. J. Neurosci. 12 2000 3117 3123
34. Y. Noda, A. Mouri, Y. Ando, Y. Waki, S.N. Yamada, A. Yoshimi, K. Yamada, N. Ozaki, D. Wang, and T. Nabeshima Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems Int. J. Neuropsychopharmacol. 13 2010 1343 1354
35. K.H. Nuechterlein, S.J. Luck, C. Lustig, and M. Sarter CNTRICS final task selection: control of attention Schizophr. Bull. 35 2009 182 196
36. I.A. Pearce, M.A. Cambray-Deakin, and R.D. Burgoyne Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells FEBS Lett. 223 1987 143 147
37. L.S. Pilowsky, R.A. Bressan, J.M. Stone, K. Erlandsson, R.S. Mulligan, J.H. Krystal, and P.J. Ell First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients Mol. Psychiatry 11 2006 118 119 (Pubitemid 43164609)
38. R.V. Popa, E.F. Pereira, C. Lopes, A. Maelicke, and E.X. Albuquerque The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease J. Mol. Neurosci. 30 2006 227 232 (Pubitemid 46035374)
39. M.D. Santos, M. Alkondon, E.F. Pereira, Y. Aracava, H.M. Eisenberg, A. Maelicke, and E.X. Albuquerque The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol. Pharmacol. 61 2002 1222 1234 (Pubitemid 34441788)
40. R. Sircar Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor upregulation Int. J. Dev. Neurosci. 21 2003 159 167 (Pubitemid 36444541)
41. M.R. Stefani, and B. Moghaddam Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia Biol. Psychiatry 57 2005 433 436 (Pubitemid 40215775)
42. Y.A. Su, X.D. Wang, J.T. Li, C.M. Guo, Y. Feng, Y. Yang, R.H. Huang, and T.M. Si Age-specific effects of early MK-801 treatment on working memory in female rats Neuroreport 22 2011 402 406
43. P. Thoma, B. Wiebel, and I. Daum Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder Schizophr. Res. 92 2007 168 180 (Pubitemid 46561240)
44. T. Uehara, T. Sumiyoshi, T. Seo, H. Itoh, T. Matsuoka, M. Suzuki, and M. Kurachi Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats Psychopharmacology (Berl) 206 2009 623 630
45. M. Van Kampen, K. Selbach, R. Schneider, E. Schiegel, F. Boess, and R. Schreiber AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors Psychopharmacology (Berl) 172 2004 375 383 (Pubitemid 38650972)
46. D. Wang, Y. Noda, Y. Zhou, A. Nitta, H. Furukawa, and T. Nabeshima Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model Neuropharmacology 52 2007 1179 1187
47. J.W. Young, and M.A. Geyer Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia Biochem. Pharmacol. 86 2013 1122 1132
48. S.J. Zhou, M.E. Zhu, D. Shu, X.P. Du, X.H. Song, X.T. Wang, R.Y. Zheng, X.H. Cai, J.F. Chen, and J.C. He Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors Brain Res. 1303 2009 74 83